BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership

Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...

April 28, 2025 | News

Suvoda and Greenphire Merge to Create Unified Platform for Streamlining Clinical Trials

Suvoda, a global clinical trial technology company specializing in randomization and trial supply management, consent, and patient outcomes data collection...

April 25, 2025 | News

Beckman Coulter Launches OptiMATE Gradient Maker to Speed Up Ultracentrifugation Workflows

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of the OptiMATE Gradient...

April 24, 2025 | News

Onward Therapeutics Receives EMA Green Light for Phase 1 Trial of Allogeneic NK Cell Therapy in Relapsed DLBCL

Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary, Emercell SAS, has ...

April 23, 2025 | News

Eisai and Biogen’s Leqembi® Secures First-of-Its-Kind EU Authorization for Early Alzheimer’s

Eisai Co., Ltd. and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (Aβ) monoclonal antibody Leqembi® (...

April 21, 2025 | News

Brain Navi Initiates IPO Counseling with First Securities to Accelerate Growth in AI-Driven Surgical Robotics

Brain Navi Biotechnology Co., Ltd. ("Brain Navi") has officially begun IPO counseling with First Securities Inc., marking a strategic step toward acce...

April 18, 2025 | News

Saudi Arabia and France Sign Strategic Agreements to Boost Collaboration in Biotech and Digital Health

Saudi Arabia and France have signed strategic agreements focusing on biotechnology and digital health. These partnerships aim to accelerate innovation, imp...

April 17, 2025 | News

Norgine to Acquire Theravia, Strengthening Its Rare Disease Portfolio Across Europe

Norgine and Theravia announced that they have entered into a definitive agreement under which Norgine will acquire Theravia, an international pharmace...

April 17, 2025 | News

United Kingdom’s Thriva and Tasso Partner to Tackle Needle Phobia with Painless At-Home Blood Testing

UK-based blood testing company Thriva has joined forces with medical device manufacturer Tasso to use their innovative blood testing technology to tackle n...

April 16, 2025 | News

Chromatin Bioscience Partners with Astellas to Advance Cell-Selective Gene Expression Technologies

Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement with As...

April 15, 2025 | News

Seegene to Introduce Vision for Fully Automated PCR Testing with CURECA™ at ESCMID Global 2025 in Vienna

- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation system expected ...

April 10, 2025 | News

Lunit Study Reveals Trust Gap Between Radiologists and AI in Real-World Breast Cancer Screening in Sweden

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the publication of a new study i...

April 10, 2025 | Report

Logistics4Pharma Expands Customs Services to Strengthen Global Pharma Supply Chains

Logistics4Pharma, a Frankfurt-based GDP-certified pharma logistics provider, has expanded its service portfolio. In addition to Temporary Storage und...

April 09, 2025 | News

Bayer Seeks U.S. Supreme Court Intervention in Missouri Roundup™ Case Amid Nationwide Labeling Disputes

Bayer – through its indirect subsidiary Monsanto – filed its petition for a writ of certiorari with the U.S. Supreme Court in the&nbs...

April 07, 2025 | News

Stay Connected